Breast cancer in Colombia is the first cause of cancer death. Post-mastectomy pain syndrome ranges from 13% to 69%; there are no regional studies evaluating its incidence among our population.Objectives:
Determining the incidence of post-mastectomy pain syndrome in patients diagnosed with breast cancer undergoing therapeutic oncology surgery at Hospital Universitario de Santander.Materials and methods:
Observational, prospective study of a cohort from January, 2014 through July, 2015 during the Pain Clinic follow-up evaluating the occurrence of post-mastectomy pain syndrome.Results:
In all, 76 patients were followed and a 55.3% incidence of the post-mastectomy pain syndrome was identified. Among them, 54.8% were classified as mild intensity (visual analog scale [VAS] <4), 42.9% as moderate intensity (VAS 5–7), and 2.4% severe intensity (VAS >8). The most frequent type of pain identified was myofascial pain (42.1%), followed by neuropathic pain (34.2%). Among the group of patients with this type of pain, a relationship was identified between age below 49 years, and this presentation (P = 0.018).Conclusions:
The incidence of post-mastectomy pain is 55.3%, higher than various world publications. We found that younger patients were more prone to develop myofascial post-mastectomy pain syndrome.